“Mantou Face” / Facial Overfilling (FOS)
What is Facial Overfill Syndrome? How is it different from “aging” or “swelling”?
Our physician’s Real-Patient Facial Overfill Correction Cases
The following four cases were personally assessed and managed by our physician at the Nanjing clinic, with authorization obtained via signed Media Release Forms. The causes, depth, and tissue-layer distribution of Filler Overfill Syndrome (FOS) vary significantly between patients; every correction plan is fully individualized. Actual outcomes are determined by in-person consultation and assessment.
Case 2 · Real FOS Documentation
- Client Profile
- Asian female · Fitzpatrick IV
- Areas of concern
- Filler Overfill Syndrome (Comprehensive multimodal combination approach)
- Treatment plan
- Hyaluronic acid filler + jawline enhancement (multiple sessions within 3 months)
- Improvement outcome
- Significant improvement in FOS · Overall result looks natural
- Post-inflammatory hyperpigmentation (PIH)
- No PIH
- Maintenance
- 9-12 months later to resume hyaluronic acid filler
Case 02: Facial Overfill Correction — Before & After · Asian Female · Fitzpatrick IV · Multimodal combination therapy led by our physician at Luowei Medical Aesthetics Clinic, Nanjing
What is Facial Overfill Syndrome? How is it different from “aging” or “swelling”?
Facial overfilling — colloquially known as “Mantou Face,” and clinically termed Filler Overfill Syndrome (FOS) — refers to the face, as a result of prolonged or excessive injections of hyaluronic acid / soft-tissue fillers,, accumulated across multiple anatomical layers, resulting in blurred facial contours, disrupted facial proportions, reduced dynamic movement, and an over-puffed “mantou” appearance — an iatrogenic facial deformity. It Not simply aging, not edema, and not weight gain, This is a newly emerging clinical issue that has grown exponentially among the North American Asian aesthetic population over the past 5–8 years.
Why doesn’t hyaluronic acid simply “metabolize within 18 months”?
Clinical evidence indicates that certain high-crosslink hyaluronic acid fillers can Residual filler persisting 5–10 years or longer, Repeated layered injections cause ongoing accumulation that far exceeds what most clients — and some clinics — recognize.
Why are Asian faces particularly prone to Facial Overfill Syndrome?
Asian facial bone structure Wider zygomatic arch, relatively flat midface, and a more understated jawline contour, Directly applying the mainstream North American “full and voluminous” aesthetic to Asian faces rapidly exceeds the anatomical capacity of Asian facial structures.
Why is “more filler = younger” an illusion?
Early filler treatments do create a genuinely more youthful appearance — but once accumulation reaches a tipping point, the result instead becomes“a” middle-aged weight gain “or persistently puffy appearance”— This is an appearance that natural aging alone would never produce.
Why must correction be physician-led?
Hyaluronidase dissolution involves Vascular, neural, and anatomical layer assessment, Over-dissolving causes collapse; under-dissolving produces no result; dissolving at the wrong plane causes distortion. This is not a procedure that can be delegated to a technician.
4 FOS clinical subtypes
Mid-cheek overfill type (most common)
SOOF Excess deposition in the dermal and subcutaneous layers, presenting as static outward bulging and compression of the lower eyelid when smiling. Most commonly seen with repeated mid-face filling.
Full-face diffuse type
Multi-zone accumulation across the temples, mid-cheeks, nasal base, and jawline — resulting in an overall loss of contour definition and facial proportion imbalance. Most commonly seen in long-term cross-clinic filler accumulation.
Tear trough / under-eye roll overfill type
Superficially placed HA creates light scattering, producing the Tyndall blue-grey discoloration and static puffiness. Particularly common in clients with repeated periorbital filler.
Refractory granuloma / inflammatory type
Most commonly seen following injection of substances of unknown origin (polyacrylamide hydrogel / PMMA). Hyaluronidase cannot fully break down these materials; a multidisciplinary correction approach is required.
Clinical Note:Many clients come in concerned that their face looks “bigger than before,” that their smile feels stiff, or that they no longer recognize themselves in old photos. They assume they have gained weight or aged — but physical examination confirms filler overfill syndrome (FOS), one of the most underrecognized clinical issues in the North American Asian aesthetic community over the past several years. Our physician’s protocol The first step is always 3D imaging + layered palpation + full injection history review., rather than proceeding directly to dissolution.
The 5 root causes of FOS — it is not simply “too much filler”
A single instance of overfilling is clinically termed “overcorrection” and typically metabolizes within 6–12 months. Facial Overfill Syndrome, by definition, requires the presence of Multi-factor accumulation for a persistent deformity to develop.
1. Long-term cumulative injections across multiple clinics and years
Patients receive repeated filler treatments at different clinics, with no single provider tracking the cumulative volume. Most FOS patients have accumulated 15–40 ml or more in total — far exceeding the anatomical tolerance of Asian faces.
2. Inappropriate aesthetic templates (applying a North American “volume and fullness” approach directly to Asian faces)
Kardashian The high cheekbone / ultra-full midface aesthetic is rooted in Caucasian bone structure. Asian faces have wider zygomatic arches and a relatively flatter midface — the same filler volume produces an entirely different visual outcome — At its visual core, FOS is an aesthetic mismatch..
3. Long-term retention of high-cross-linked HA in facial tissue
Certain high-G’ hyaluronic acid fillers — particularly larger-particle formulations — can persist for 5–10 years in low-metabolism facial zones. With repeated layering, they create a “permanent mass effect,” rendering standard metabolic timelines completely unreliable.
4. Incorrect injection depth / superficial overfill
Excess filler in the superficial subcutaneous and deep dermal layers creates Static outward bulging + dynamic stiffness. Some clinics opt for superficial injections to achieve quick visible results — an approach that reliably leads to FOS within a few years.
5. Non-HA fillers (permanent fillers / unidentified substances)
Permanent and semi-permanent fillers — including polyacrylamide hydrogel (Aquamid), silicone oil, PMMA, and unverified “collagen” products — cannot be dissolved by hyaluronidase. These represent the most complex category of FOS cases and often require multidisciplinary management.
4 Conditions commonly confused with FOS — key differential diagnosis points
Misclassification leads to mismanagement. Treating FOS as weight gain (and pursuing fat reduction) or as aging (and pursuing lifting procedures) will cause the condition to worsen. The table below outlines the 4 most common differential diagnoses our physician encounters in clinical practice.
Facial Fat Gain
Subcutaneous Fat Hypertrophy
| Distribution | Uniform across the entire face, correlating with body weight changes |
|---|---|
| Texture | Soft, pinchable, and resilient |
| Injection history | Typically none |
| Triggering factors | Weight gain / hormonal changes / age |
| First-line approach | Weight management / localized fat reduction (not hyaluronidase dissolution) |
Age-Related Facial Ptosis
Facial Aging / Volume Descent
| Distribution | Midface descent + loss of jawline definition |
|---|---|
| Texture | Relaxed, not externally bulging |
| Injection history | Typically absent / mild in early stages |
| Triggering factors | True age + collagen loss |
| First-line approach | Sofwave / Thermage® FLX / Thread Lift |
Chronic Facial Edema
Facial Lymphedema
| Distribution | More pronounced in the morning, reduced by evening; pits on pressure |
|---|---|
| Texture | Soft, with visible indentation on pressure |
| Injection history | Optional |
| Triggering factors | Lymphatic drainage impairment / renal function / allergy |
| First-line approach | Internal medicine workup + lymphatic drainage |
Filler Overfill Syndrome — FOS (primary condition)
Filler Overfill Syndrome
| Distribution | Cheek (midface) / temple / nasal base / under-eye roll injection sites |
|---|---|
| Texture | Relatively firm / hard, with a defined border |
| Injection history | Documented history of repeated filler treatments |
| Triggering factors | Cumulative injection history + high-cross-linked filler retention |
| First-line approach | HA Hyaluronidase dissolution + Sculptra® remodeling |
⚠️ Important:Clinically, a subset of patients who initially request facial liposuction or jawline liposuction are re-classified as FOS (Filler Overfill Syndrome) after physical palpation and a thorough review of their injection history. In these cases, proceeding with liposuction would disrupt normal anatomical structures and would not address the actual problem.Before beginning revision, it is essential to confirm that the presentation is indeed filler-related, This is the most significant knowledge gap among Asian patients seeking aesthetic treatment.
Why must FOS correction for Asian faces use an Asian bone structure-specific approach?
A blind spot in most mainstream North American clinics
Most medical aesthetic clinics in North America base their filler dosing and injection-site parameters on Caucasian bone structure — characterized by midface concavity, narrow zygomatic arch, and a more prominent mandible. Applying these same parameters directly to Asian faces produces three core problems:
- ✗ Volume overload— The Asian midface is naturally flatter and relatively fuller, so the same volume in milliliters produces a far more pronounced visual impact.
- ✗ Injection site mismatch— In Caucasian patients, injecting the upper-outer cheek area projects a youthful appearance; in Asian faces, the same technique visually widens the zygomatic arch
- ✗ Aesthetic misguidance— The refined quality of Asian faces comes from dimension, proportion, and restraint — not volume.
Our physician’s Asian bone structure-specific correction approach
| Assessment parameters | North American standard | Asian-specific adjustment |
|---|---|---|
| Mid-cheek volume | High-projection volume enhancement | Understated / Three-dimensional |
| Jawline | Square and anteriorly projected | V Contour convergence |
| Dissolution strategy | Full single-session dissolving | Zone-by-zone staged |
| 3D Assessment | Optional | Required (VECTRA) |
| Injection history review | Brief intake / simple consultation | Session-by-session reconstruction of products used and volumes injected |
6 treatment approaches for FOS correction — selected by clinical subtype
There is no single vial of hyaluronidase that resolves everything. We design a combination of the devices and therapies listed below based on the depth, extent, and filler type involved in each case.
FOS Revision Protocol (developed by our physician)
Integration Injection history review + 3D quantitative assessment + zone-by-zone staged dissolution + structural support during the rebuilding phase a comprehensive correction system — not a single-session dissolve, but a 3–9 month structural restoration plan, calibrated specifically for Asian facial anatomy.
Precision Hyaluronidase Dissolution
NMPA-registered hyaluronidase is used, administered by anatomical layer and zone with targeted injections — treating only 1–2 zones per session, with a 4–6 week observation interval between sessions.Must be performed by the physician personally, Involves assessment of the vascular plane and precise dose calculation.
Sculptra (poly-L-lactic acid)
Once the dissolution phase is complete and mild volume loss becomes apparent in certain areas, Sculptra® is used to Supraperiosteal / deep SMAS layer gradually stimulate the body’s own collagen — rebuilding structure rather than simply “refilling” volume.
Sofwave / Thermage® FLX (energy-based tightening)
Used in the later stages of correction, via focused ultrasound / monopolar radiofrequency Tightening the skin envelope that has been stretched over time, Helping the facial contour re-conform to the underlying bone structure.
Thread Lift (PDO / PLLA Thread Lift)
Used as an adjunct during the correction phase to address laxity in the mid and lower face — particularly suitable for patients who develop mild sagging after dissolving.Not used as the primary treatment — only as a supporting measure.
Skin booster injections + barrier repair protocol
Long-term filler accumulation is often accompanied by skin envelope thinning and compromised barrier function. During the revision period, skin-booster injections combined with barrier-repair skincare are used to restore skin texture and resilience — Not re-injection — nourishment..
Our physician’s 6-step standardized FOS correction protocol
Consultation + comprehensive injection history review
30 minute free consultation to reconstruct your injection history — products, volumes, and sites over the past 5–10 years — without judgment. Includes VECTRA 3D imaging, layered palpation assessment, and ultrasound assistance when indicated.No dissolution without a full injection history review.
Zone mapping + revision roadmap
Mapped on the 3D model Overfilled zones / Normal zones / Volume-deficient zones, our physician maps out a 3–9 month correction roadmap so clients understand the purpose, risks, and expected visual changes at every step.
First dissolution session (test dose)
Begin with the most clearly overfilled zone, using Test low dose HA Hyaluronidase dissolution, followed by 2–4 weeks of observation. This step screens for individual enzyme sensitivity and confirms the correct revision direction.
Active Revision Phase (2–5 dissolution sessions, once every 4–6 weeks)
Zones are dissolved sequentially according to priority. Only 1–2 zones are addressed per session to prevent sudden volume collapse.Staged “imperfection” is an accepted and expected part of the correction phase This is the aspect of treatment that requires the most expectation management for Asian patients.
Assessment Phase (8–12 weeks after the active revision phase)
VECTRA 3D Re-assessment with quantified palpation comparison. Decision made on whether to proceed to the rebuilding phase (Sculptra® / energy-based tightening) or to continue with observation and maintenance.
Remodeling phase + long-term management
Sculptra, Sofwave™, and barrier repair introduced as needed.The key is establishing a new set of injection discipline principles— Annual assessment with a single physician only — no further cross-clinic accumulation.
Correction Timeline — How Long Before You Recognize Yourself in the Mirror Again?
| Subtype | Number of dissolution sessions | Initial changes | Significant improvement | Full treatment cycle |
|---|---|---|---|---|
| Localized overfill (single zone) | 1–2 session | 2 Within weeks | After Session 1 | 2–3 months |
| Multi-zone overfill | 3–5 session | 1 months | After the 3rd session | 4–6 months |
| Full-face diffuse type | 5–8 session | 2 months | After the 5th session | 6–9 months |
| Including non-HA / granulomatous types | Requires multidisciplinary management | Case-dependent | Case-dependent | 9–18 months |
Clinical Note:Rushing the revision process is one of the most common mistakes. Over-dissolving in a single session can cause collapse, which triggers the urge to refill — restarting the same accumulation cycle. Among our Nanjing clients, those who complete the full revision protocol and establish disciplined injection habits consistently show far greater long-term facial stability than the general aesthetic population.
Do You Have FOS? 2-Minute Self-Assessment
✅ High suspicion · Consultation recommended
- ✓Cumulative hyaluronic acid filler injections over the past 3–10 years, with no clear recollection of total volume
- ✓Compared to photos from 5 years ago, the face looks noticeably larger, squarer, or less defined.
- ✓The face feels stiff when smiling / the cheeks push up against the lower eyelids.
- ✓No change in body weight, yet others comment that you look “like you’ve gained weight”
- ✓Bluish-grey discoloration visible through the skin (Tyndall effect) in the under-eye roll, tear trough, or temple area
- ✓Palpation reveals a firm or clearly delineated feel beneath the skin.
❌ Treatment should be postponed or other concerns should be assessed first
- ✗Currently pregnant or breastfeeding (treatment recommended after delivery and cessation of breastfeeding)
- ✗Active facial infection, inflammation, or severe acne flare
- ✗Prior history of severe allergy to hyaluronidase
- ✗Expecting one dissolution session followed by immediate refilling (a fundamental misconception)
- ✗Uncontrolled autoimmune disease in an active flare
- ✗Facial swelling due to unresolved weight or endocrine issues
Luowei Physician-Led FOS Revision vs. Standard MedSpa
- ✗Proceeding to dissolve after a brief visual inspection, without reviewing injection history
- ✗Single full-face hyaluronidase dissolving session, resulting in immediate collapse
- ✗Non-HA fillers are not recognized by hyaluronidase — blind dissolution is ineffective.
- ✗Recommending immediate re-filling right after dissolution
- ✗Procedures frequently performed by RNs or Aestheticians
- ✗No 3D imaging — assessment based entirely on subjective judgment
- ✗No structural rebuilding phase — just a cycle of “dissolve → refill.”
- ✓Required: injection history review + VECTRA 3D + layered physical examination
- ✓Staged zone-by-zone dissolution (one zone every 4–6 weeks)
- ✓Ultrasound-assisted identification of non-HA materials; multidisciplinary referral when indicated
- ✓After dissolution, allow the face to remain slightly “deflated” — do not refill immediately
- ✓Personally assessed and performed by our physician
- ✓Quantitative comparison imaging and a fully transparent revision roadmap throughout
- ✓Sculptra + Sofwave™ structural rebuilding — not re-filling
Why is Luowei Medical Aesthetics Clinic a trusted source for filler overfill revision?
Experience
Expertise Specialty
Authoritativeness Authority
Trustworthiness Trustworthy
All cases on this page are authorized via signed Media Release Forms · Complete injection histories on record
Pricing for Facial Overfill Correction
Performed entirely by our physician · VECTRA 3D assessment + zone-by-zone dissolution planning · Complex presentations / correction-phase injections / multidisciplinary consultation
Licensed Aesthetic Technician performs energy-based adjunct treatments under our physician’s protocol · Standard protocols apply.
HA Staged hyaluronidase dissolving + Sculptra® rebuilding + Sofwave™ tightening — combination therapy
Pricing for facial overfill correction varies widely between clinics — but the true cost has never been about “how much per vial of enzyme.” It is about who performs the assessment, and who determines the dissolution depth, dosage, and sequencing for each zone. FOS correction involves facial vascular and nerve anatomy, layer-by-layer judgment, and reverse-engineering years of cumulative filler. Over-dissolving causes collapse; under-dissolving achieves nothing; dissolving at the wrong plane causes distortion. Our physician personally leads all such decisions, and the pricing reflects that level of medical investment. For straightforward single-zone, mild, or recently injected cases, our trained clinical team may assist under our physician’s protocoldissolving safely within appropriate parameters — a more accessible option. However, any injectable procedure (including hyaluronidase, Sculptra®, or injections during the correction phase) is performed exclusively by the physician. The price difference between laser and energy-based adjunct treatments reflects the clinical experience gap between physician-performed and technician-performed procedures. Which approach is right for you is determined by your clinical presentation and FOS subtype — not by price. The specific plan will be discussed at your consultation based on your 3D assessment and injection history.
- Payment is made at the clinic, after the consultation and before treatment begins
- Nothing is paid in advance, and no deposit is required to hold an appointment
- Cosmetic treatment is a self-pay item and is not covered by public medical insurance in China
- All new clients receive a complimentary 30-minute Free Consultation & Assessment
Risks & Contraindications — Full Transparency
What are the main risks?
1. Transient hollow sensation caused by over-dissolving(within the expected range and manageable through a staged zone-by-zone approach); 2. Localized bruising / swelling (common; resolves within 5–10 days); 3. Allergic reaction to hyaluronidase (rare; a skin test is required prior to first treatment); 4. Non-HA fillers cannot be dissolved with enzyme and require multidisciplinary intervention; 5. Psychological adjustment during the correction period (transitioning from “overfilled” to “normal” requires emotional preparation).
Who is absolutely not a candidate?
Pregnancy, breastfeeding, a history of severe allergy to hyaluronidase, active facial infection, uncontrolled autoimmune disease, uncontrolled coagulation disorder, or unrealistic expectations (believing one session will dissolve everything and immediately restore beauty) — in any of these situations, our physician will recommend postponing treatment or addressing the underlying health concern first.
How is collapse and discomfort minimized during revision?
5 core principles: (1) Always dissolve in zones and stages — never the entire face at once; (2) Start at the lower end of the dose range and titrate upward gradually; (3) Allow a minimum of 4 weeks between sessions; (4) Set realistic expectations for the correction phase — accept that the face will look temporarily deflated before it recovers; (5) Return immediately for a follow-up if any discomfort persists beyond 7 days.
What does the informed consent form include?
Every client signs an informed consent form before their first revision session. It covers: the mechanism of hyaluronidase dissolution, possible adverse reactions and their likelihood, expected visual changes at each stage, criteria for pausing treatment, follow-up scheduling, and an optional Media Release. Our physician personally walks through every item — it is never delegated to administrative staff.
Where the medical claims on this page come from
Everything above about “Mantou Face” / Facial Overfilling (FOS) rests on published evidence rather than on our own word. The sources below are the ones behind those statements: peer-reviewed papers indexed in PubMed, and guidance written for patients by dermatology academies and national health services. Read them before you decide — and bring any of them to your consultation.
- Peer-reviewedBotulinum toxin type A for facial wrinkles
- Peer-reviewedBotulinum Toxin Treatment for Mild to Moderate Platysma Bands: A Systematic Review of Efficacy, Safety, and Injection Technique
- Patient guidanceWrinkles
- Patient guidanceDermal fillers: Overview
- Patient guidanceBotulinum toxin: Overview
What these references can and cannot tell you. They describe what is known about the treatment itself — how well it tends to work, how long results last, and what can go wrong. They are not an assessment of this clinic, and no published study can tell you whether it suits your skin type, anatomy, or medical history. That judgement comes from the physician who examines you in person, and it may well be “not this one”.